期刊文献+

能量可控陡脉冲联合H-ras干扰性RNA治疗卵巢癌裸鼠皮下移植瘤的实验研究 被引量:4

Experimental study of energy controllable steep pulses and RNA interference targeting H-ras gene on inhibiting growth of xenografted tumor of ovarian cancer cells
下载PDF
导出
摘要 目的 利用陡脉冲电场的可逆性电穿孔电转基因,观察陡脉冲治疗仪联合基因治疗对肿瘤生长的影响。方 法 构建抗H- ras基因表达的小发夹状RNA重组质粒载体(pshRNA H- ras);建立卵巢癌荷瘤裸鼠模型,光、电镜观察陡脉 冲对肿瘤组织的病理学改变,荧光报告质粒观察陡脉冲电场的可逆性电穿孔;实验分为4组:对照组、陡脉冲治疗组、陡脉 冲加基因单次干扰治疗组和加基因重复干扰治疗组,记录治疗后21d各荷瘤鼠肿瘤的体积和体质量。结果 陡脉冲对肿 瘤组织有明显的破坏作用,肿瘤边缘残存有活性的癌细胞;各治疗组肿瘤体积与体质量明显低于对照组,差异具有极显著 性(P<0.01),其中,陡脉冲加基因重复干扰治疗组肿瘤体积和重量显著低于仅用陡脉冲治疗组(P<0.01)。结论 陡脉 冲是一种新型有效的治癌工具,联合基因治疗能更有效地抑制肿瘤生长。 Objective To evaluate the effects of energy controllable steep pulses(ECSP) and the small hairpin RNA recombinant plasmid targeting H-ras gene (pshRNA/H-ras) on the growth of xenografted ovarian tumor cells. Methods The recombinant plasmids targeting H-ras gene coding sequence (pshRNA/H-ras) were constructed successfully. ECSP were applied to ovarian tumor-bearing nude mice. After exposed to ECSP, tissues were obtained and present for routine HE and transmission electron microscope (TEM) observation. The reversible electroporation were observed by fluorescent reporter plasmids. Tumor modeling were achieved in 20 nude mice and divided into four groups: ECSP group, ECSP and pshRNA/H-ras 1 (injecting one time), ECSP and pshRNA/H-ras 4 (injecting 4 times), and unexposed group. The volume and weight of tumors in each group were recorded at predetermined times. Results ECSP show effectively destructive action as compared with unexposed group. Irreversible cell changes could be seen under TEM. There were survived cells close to the necrotized regions. The volume and weight of tumors in each experimental group were significantly smaller than unexposed group (P<0.01). In ECSP and pshRNA/H-ras 4 group, ECSP was far more effective than ECSP group in retarding tumor growth (P<0.01). Conclusion ECSP is a new and effective way for solid tumor treatment and can inhibit the growth of tumors with the combination of gene method.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2005年第6期490-493,共4页 Journal of Third Military Medical University
基金 国家自然科学基金资助项目(30371619)~~
关键词 能量可控陡脉冲 RNAI 基因 H-ras 卵巢肿瘤 肿瘤 energy controllable steep pulses (ECSP) RNA interfering gene, H-ras ovarian neoplasms neoplasms
  • 相关文献

参考文献7

  • 1Okino M, Mohri H. Effects of a high-voltage electrical impulse and anticancer drug on in vivo growing tumors[J]. Jpn J Cancer Res, 1987, 78(12): 1319-1321.
  • 2Weaver J C. Electroporation: a general phenomenon for manipulating cells and tissues[J]. J Cell Biochem, 1993, 51(4): 426-435.
  • 3胡娅,胡丽娜,米彦,姚成国,熊兰,孙才新.能量可控陡脉冲对人卵巢癌细胞的体外作用[J].第三军医大学学报,2003,25(16):1441-1445. 被引量:27
  • 4王丰,陈霞芳,田毓华,吴继红,李凌,李川源,黄倩.电穿孔介导质粒DNA肿瘤内转移抑制恶性肿瘤生长与转移[J].生物化学与生物物理进展,2002,29(5):734-740. 被引量:11
  • 5Tomoaki Goto, Toru Nishi, Takahiko Tamura, et al. Highly efficient electro-gene therapy of solid tumor by using an expression plasmid for the herpes simplex virus thymidine kinase gene[J]. Proc Natl Acad Sci U S A, 2000, 97(1): 354-359.
  • 6Takeshi Suzuki, Bo-Chul Shin, Keiko Fujikura, et al. Direct gene transfer into rat liver cells by in vivo electroporation[J]. FEBS Lett, 1998, 425: 436-440.
  • 7Gong Yang, Jennifer Anne Thompson, Bingliang Fang, et al. Silencing of H-ras gene expression by retrovirus-mediated siRNA decreases transformation efficiency and tumorgrowth in a model of human ovarian cancer[J]. Oncogene, 2003, 22(36): 5694-5701.

二级参考文献18

  • 1温汉平,王小宁.肿瘤细胞体外药敏试验MTT分析法[J].中华肿瘤杂志,1993,15(6):470-471. 被引量:63
  • 2张锦珠,孔克健,鲁崎唔,董仁杰.脉冲电场对人红细胞膜结构影响的冷冻断裂研究[J].实验生物学报,1994,27(2):183-191. 被引量:3
  • 3朱帆三,陈柏好,林家瑞,谢则平.R波同步电脉冲治疗癌症的实验研究[J].中国生物医学工程学报,1995,14(4):299-305. 被引量:2
  • 4Shalaby F, Rossant J, Yamaguchi T P, et al. Failure of blood-island formation and vasculogenesis in Flk-1 deficient mice. Nature, 1995, 376(6535): 62~66
  • 5Sato T N, Tozawa Y, Deursh U, et al. Distinct roles of the receptor tyrosine kinase Tie-1 and Tie-2 in blood vessel formation. Nature, 1995, 376(6535):70~74
  • 6Dumont D J, Gradwohl G, Fong G H, et al. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev, 1994, 8(16):1897~1909
  • 7Lohr F, Lo D Y, Zaharoff D A, et al. Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation. Cancer Res, 2001, 61(8):3281~3284
  • 8Duda D G, Sunamura M, Lozonschi L, et al. Direct in vitro evidence and in vivo analysis of the antiangiogenesis effects of interleukin 12. Cancer Res, 2000, 60(4):1111~1116
  • 9Paul D, Qazilbash M H, Song K, et al. Construction of a recombinant adeno-associated virus (rAAV) vector expressing murine interleukin-12 (IL-12). Cancer Gene Ther, 2000, 7(2):308~315
  • 10Caruso M, Pham-Nguyen K, Kwong Y L, et al. Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma. Proc Natl Acad Sci USA, 1996, 93(21):11302~11306

共引文献30

同被引文献40

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部